Design, Biological Characterization, and Discovery of Capromorelin Derivatives as Oral Growth Hormone Secretagogue Receptor Type 1a Agonist for the Treatment of Growth Hormone Deficiency Journal of Medicinal Chemistry The growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin induced weight loss in ferrets: Anamorelin also exhibits anti emetic effects via a central mechanism ScienceDirect CJC 1295 + Ipamorelin (10mg) G Lab Peptides Ipamorelin is not GH, but smaller. It's a selective GHSR agonist studied for pulsatile GH release, with minimal cortisol prolactin effect in research. Stacked is tracking 30 listings from $2.80 mg today. #PeptideResearch